Background/Aims: Several factors influencing postoperative pain and the effect of opioid analgesics have been investigated on an individual level. The aim of this study was to clarify the impact of catecholamine-O-methyltransferase (COMT) gene Val158Met on opioid consumption in postoperative patients. Methods: A systematic review and meta-analysis of the literature up to September 30, 2017, were performed by using PubMed, Cochrane Library, ISI Web of Science, and Chinese National Knowledge Infrastructure (CNKI) database. The meta-analysis examined all studies involving the association between genetic polymorphisms of COMT Val158Met and opioid consumption during the acute postoperative period. Results: Of the 153 identified studies, 23 studies were retrieved for systematic review and 10 studies were retrieved for meta-analysis. However, it was impossible to conduct metaanalysis on the association between COMT Val158Met polymorphism and postoperative pain because of heterogeneity of the data. Overall, meta-analysis showed that COMT Val/ Met carriers consumed less opioid for analgesia within the first 24 hours after surgery (SMD = 0.14, 95% CI = [0.03, 0.25], P = 0.01) but not within 48 hours (SMD = 0.14, 95% CI = [0.08, 0.36], P = 0.21). There was no significant difference in opioid consumption between Val/ Val and Met/Met patients. Conclusion: Patients with Val/Met but not Met/Met allele variant consumed less opioid, though larger and better-designed studies are required to obtain an exclusive conclusion about the correlation between postoperative pain and COMT Val158Met polymorphism.
Introduction
Patients undergoing major surgery are often inflicted with acute pain during the postoperative period, and their pain perception and response to analgesics vary greatly with individuality and are affected by several factors including difference in the type of procedures, sex, age and genetic variation [1, 2] . Recently, polymorphisms of several genes have been recognized as a potential risk factor for the severity of acute postoperative pain [3] [4] [5] . However, what genes contribute to the variability of pain perception and analgesic effects remains unclear.
The catecholamine-O-methyltransferase (COMT) gene is located at the gene map locus of 22q11.2 and encodes the COMT protein [6] . Ample evidence has shown that singlenucleotide polymorphisms (SNP) in COMT are associated with pain perception [7, 8] . The most studied SNP in COMT gene is rs4680, which is known as a functional polymorphism. G to A transition results in a valine (Val) to methionine (Met) amino-acid substitution. It may cause three possible SNP genotypes: GG (Val/Val) genotype, which has high enzymatic activity, AA (Met/Met) genotype, which produces defective enzymes, and GA (Val/Met) genotype, which has moderate enzymatic activity [9, 10] .
COMT metabolizes biogenic amines including dopamine, epinephrine, and norepinephrine, and therefore its activity would affect the opioid behaviors [11] . Opioids are common analgesics used for pain management, especially after surgery. The sensitivity to pain and the response to analgesics, even following the same surgery, are highly variable among patients [12] . Therefore, exploring conclusive evidence of the association between COMT genetic variants and the analgesic effects of opioids is clinically significant. However, there is no systematic review and meta-analysis about the association between the COMT Val158Met gene polymorphism and postoperative pain and opioid analgesics. In this article, we summarize retrieved studies to clarify the effect of COMT genetic variants on pain and the analgesic effect of opioids in patients with postoperative pain.
Materials and Methods

Search strategy
This review was performed according to the Preferred Reporting Item for systematic reviews and Meta-Analysis (PRISMA). Studies were identified through the databases of PubMed, Cochrane Library, ISI Web of Science, and Chinese National Knowledge Infrastructure (CNKI), which were published in English and Chinese. The final search strategy was as follows: (("Pain, Postoperative" 
Study selection and inclusion criteria
We included eligible studies that met the following criteria: (1) observational cohort studies, casecontrol studies, and randomized controlled trials; (2) studies reporting any type of surgery in adults; (3) studies reporting the postoperative following-up time between 24 and 48 hours; (4) pain assessed by primary outcome parameters; (5) opioid consumption in patients after surgery; and (6) studies measuring genetic polymorphisms directly. The following information was abstracted from each study: first author, year of publication, surgery setting, COMT polymorphisms, ethnicity of participants, Hard-Weinberg equilibrium, opioid category, and main finding of the study.
Data extraction and analysis
The titles and abstracts of the retrieved studied were independently screened by more than three investigators. Studies were excluded if they failed to meet the above-mentioned criteria. The full texts for the included articles were obtained and further assessed.
Statistical analysis
We considered performing a meta-analysis for polymorphisms that were reported by more than three studies. The association between COMT gene Val158Met polymorphisms and opioid consumption was calculated by the mean difference (MD) or STD mean difference (SMD) and corresponding 95% confidence interval (95% CIs). The heterogeneity between these studies was evaluated using the Cochrane Q-test (significant at P < 0.05) and I 2 test (low heterogeneity = 25%, moderated heterogeneity = 50%, high heterogeneity = 75%) in the random effect model.
Results
Characteristics of the studies
There were 23 studies relevant to the search words, and 10 studies were included in meta-analysis. The flow chart of selection of studies and reasons for exclusion is presented in Fig. 1 . The study characteristics are summarized in Table 1 . The COMT genotypes fell into three very distinct genotypes; GG (Val/Val), GA (Val/Met) and AA (Met/Met).
Systematic review of COMT and postoperative pain
Single-nucleotide polymorphism rs4680 in the COMT enzyme gene has been extensively studied in association with pain perception, including acute and chronic pain [13] [14] [15] [16] . The Met/Met carrier is associated with a 3-4 fold reduction in COMT enzyme activity compared with the Val/Val carrier. The AA (Met/Met) allele diminished the regional µ-opioid system responding to pain and increased the µ-opioid receptor binding potential [17] , suggesting that the increased density of opioid receptor of the Met/Met carrier may improve the efficacy of morphine. Some postoperative studies showed that the Met/Met carrier was associated with the highest pain scores compared with patients with the wild type (Val/Val) [18] [19] [20] [21] . Controversially, according to the study of Wesmiller and Henker, Val/Val patients had significantly high pain scores after surgery [22, 23] . Furthermore, several other studies Characteristics of the studies included in meta-analysis. Note: NA: Not available; LPS: Low pain sensitivity; APS: Average pain sensitivity; HPS: High pain sensitivity also found that COMT variants had a small effect on pain perception [24] [25] [26] [27] [28] [29] [30] . We performed meta-analysis to explore the association between pain perception and COMT polymorphisms but failed to find significant differences between the three types of variants in pain scores. Heterogeneity in the meta-analysis was severe, and therefore the correlation between COMT and postoperative pain needs to be further investigated in the future.
Other than rs4680 in the COMT gene, several other SNPs were also reported to be associated with pain sensitivity, including rs6269, rs4633 and rs4818 [12, 26] . These four SNPs of COMT were used to construct three pain sensitivity haplotypes: low pain sensitivity (LPS; GCGG), average pain sensitivity (APS; ATCA), and high pain sensitivity (HPS; ACCG) [31] . In Tan's study, they found that LPS haplotype had the highest pain score [25] . In contrast, the results form Orrey and Kolesnikov suggested that patients without LPS haplotype had maximum pain and would require a higher opioid amount [21, 32] . Meanwhile, APS haplotype might associate with the lowest pain perception but involve long-term postsurgical pain [33, 34] . Besides the haplotype of COMT, the interaction between OPRM1, sex, and COMT may also affect patients' pain perception [12, 35] .
Meta-analysis of Val/Val-Val/Met and opioid consumption
Ten studies [19, 21, 23, 25-27, 30, 33, 36, 37] reported opioid consumption within the first 24 hours in their meta-analyses, and 4 studies [21, 23, 26, 30] reported opioid consumption within 48 hours. These studies included 808 patients for Val/Val and 807 patients for Val/ Met within 24-hour. Several kinds of opioids were tested in all studies. Within first 24 hours after surgery, Val/Met carriers exhibited significant low opioid consumption compared with Val/Val carriers ( Fig. 2A , random model: SMD = 0.14, 95% CI= [0.03, 0.25], P = 0.01, P heterogeneity = 0.39). However, we did not find the same trend 48 hours after surgery (Fig. 2B , random model: SMD = 0.14, 95% CI = [0.08, 0.36], P = 0.21, P heterogeneity = 0.7). No heterogeneity was found across all the studies. 
Meta-analysis of Val/Val-Met/Met and opioid consumption
The GG (Val/Val) genotype of COMT included 808 patients, and AA (Met/Met) genotype included 294 patients for the first 24-hour after surgery. The studies included 166 patients for GG (Val/Val) and 53 patients for AA (Met/Met) genotype within 48 hours. Overall pooled analysis indicated no significant difference in opioid consumption between Val/Val and Met/ Met carriers within the first 24 hours (Fig. 3A , random model: SMD = 0.11, 95% CI = [-0.14, 0.36], P = 0.41, P heterogeneity = 0.01) and 48 hours (Fig. 3B , random model: SMD = 0.07, 95% CI = [-0.25, 0.39], P = 0.67, P heterogeneity = 0.95) after surgery. Since the heterogeneity was significant in patients 24 hours after surgery, we performed Galbraith's test to estimate all 10 studies and singled out the study from Wesmille [22] as the main contributor to heterogeneity (Fig. 4A) . After excluding this study, the heterogeneity disappeared but still no significant association was found ( (Fig. 5) .
Discussion
Acute postoperative pain is an inevitable problem encountered in clinical practice and often results in multiple outcomes if an inadequate pain management is applied. The worst consequence is a chronic postoperative pain. Increasing evidence suggests that genetic factors significantly contribute to individual differences in pain perception, and are associated with risk for developing chronic pain conditions [13, 38] . The COMT gene is polymorphic, and the variants include rs4680, rs6269, rs4633, rs4818, rs165774, rs174696 [39] [40] [41] . In previous studies, it reported that these COMT SNPs associate with pain and analgesic effect. But the most widely studies variant in this gene SNP was adenosine (A) to guanosine (G) substitution at sequence 4680. Val158Met variant of COMT causes enzyme activity and affects pain perception in volunteers [17, 42] . Although considerable studies suggest that SNP rs4680 of COMT associated with pain and opioid consumption, the reported data are unable to get a convincible conclusion. Hence, we performed a systematic review and meta-analysis to evaluate the association between COMT gene Val158Met polymorphism and postoperative pain and opioid consumption.
AA (Met/Met) allele is known to be associated with reduced enzyme activity and difference in the clinical dose of opioids between individual patients suffering from cancer and undergoing major surgery [36, 43] . Most investigations focused on the difference in pain or opioid consumption between AA (Met/Met) and GG (Val/Val) allele. Although we found that AA (Met/Met) homozygotes were not significantly associated with opioid consumption, GA (Val/Met) heterozygote carriers required lower opioid doses compared with Val/ Val carriers and there was no bias publication in all studies. Therefore, the GA (Val/Met) heterozygotes should be further investigated in the future.
There was no significant correlation between the COMT gene Val158Met polymorphism and opioid consumption within 48 hours after surgery. There may be two reasons for this. Firstly, the data included in the meta-analysis were so small that limited the statistical significance. In addition, pain management was applied to patients who suffered less pain in 48 hours.
In this study, we failed to find any significant association between postoperative pain and COMT gene Val158Met polymorphism. We further explored all the data and found most of the present 10 studies used in meta-analysis were population-mixed. COMT variants have different distributions in Caucasian and Asian populations [25] . Such as, the frequency of AA allele (Met/Met) in Caucasians ranges from 0.53 to 0.63, while its frequency in East Asians ranges from 0.11 to 0.35. Hence, the AA (Met/Met) allele is the major allele in Caucasian population but not in East Asians [44] . These inconsistencies in the COMT variants and population might be the major reason.
Pain perception and opioid analgesic response are complex traits, which are likely to be modulated by gene and gene-gene network. COMT gene has four important SNPs: rs4680, rs6269, rs4633 and rs4818, all of which produce three pain sensitivity haplotypes: HPS, APS, and LPS. The present study failed to obtain an exclusive conclusion, but the correlation between the haplotype and opioid consumption cannot be ignored [12, 25, [32] [33] [34] 45] . Furthermore, some recent studies have begun to explore the relationship between genegene (COMT and OPRM1) interactions to the pain susceptibility and opioid analgesic effect. Patients having AA (Met/Met) of COMT rs4680 and AG of OPRM1 rs1799971 consumed the largest amount of opioid compared to those having other combinations after orthopedic surgery [12] . While Henker revealed that heterozygous patients with GA (Val/Met) of COMT and AG of OPRM1 consumed significantly less morphine in the postanesthetic recovery room and 48 hours after surgery [21] . Besides the postoperative pain, many studies found that carriers of the COMT AA (Met/Met) and OPRM1 AA genotype required the lowest opioid dose compared to other combinations in cancer pain [33, 46] . But we could not get an exclusive conclusion, larger randomized studies involving postoperative patient screening for the COMT and OPRM1 mutation are needed. Hence, more genes and variants need to be discovered to explain the phenotypic variance in the analgesic effect of opioids.
In summary, the present meta-analysis indicates that the studied SNP rs4680 of COMT had insignificant association between 24-and 48-h postoperative pain. Patients with COMT rs4680 GA (Val/Met) heterozygotes consumed lower opioid does than those with GG homozygotes within 24 hours after surgery, which might provide valuable information for clinicians to better manage the use of opioids and pain individually.
